// App-Quantinova.ai

2998 : Real-World Treatments and Thrombotic Events in Polycythemia Vera Patients: A Retrospective Analysis between 2018-2019 in US Population

Researchers

Presenter

  • Srdan Verstovsek

Principal Investigators

  • Ariel Han

  • Karin Chun Hayes

  • Tracy Woody

  • Frank Valone

  • Suneel K Gupta

Medical Centers

  • Department of Bioinformatics, The University of Texas MD Anderson Cancer Center, Houston, TX

  • PRA International, Symphony Health, Blue bell, PA

  • PRA International, Symphony Health Solutions, Phoenix, AZ

  • Protagonist Therapeutics, Newark, CA

  • Protagonist Therapeutics, Mill Valley, CA

  • Protagonist Therapeutics, Sunnyvale, CA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Myeloid neoplasms

  • Polycythemia vera

  • Venous thrombosis

Biomarkers

  • Hematocrit

Drug/Treatment

  • Hydroxyurea

  • Hydroxycarbamide

  • Ruxolitinib phosphate

  • Interferon

  • Busulfan

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved